A protein domain-oriented approach to expand the opportunities of therapeutic exon skipping for USH2A-associated retinitis pigmentosa
Loss-of-function mutations in USH2A are among the most common causes of syndromic and non-syndromic retinitis pigmentosa (RP). We previously presented skipping of USH2A exon 13 as a promising treatment paradigm for USH2A-associated RP. However, RP-associated mutations are often private, and evenly d...
Saved in:
Main Authors: | Renske T.W. Schellens (Author), Sanne Broekman (Author), Theo Peters (Author), Pam Graave (Author), Lucija Malinar (Author), Hanka Venselaar (Author), Hannie Kremer (Author), Erik De Vrieze (Author), Erwin Van Wijk (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Natural Exon Skipping Sets the Stage for Exon Skipping as Therapy for Dystrophic Epidermolysis Bullosa
by: Jeroen Bremer, et al.
Published: (2019) -
Targeted Exon Skipping to Correct Exon Duplications in the Dystrophin Gene
by: Kane L Greer, et al.
Published: (2014) -
Antisense Oligonucleotide-based Splice Correction for USH2A-associated Retinal Degeneration Caused by a Frequent Deep-intronic Mutation
by: Radulfus WN Slijkerman, et al.
Published: (2016) -
Targeted exon skipping of NF1 exon 17 as a therapeutic for neurofibromatosis type I
by: André Leier, et al.
Published: (2022) -
Targeted Exon Skipping to Address "Leaky" Mutations in the Dystrophin Gene
by: Sue Fletcher, et al.
Published: (2012)